[ET Net News Agency, 14 August 2024] HANSOH PHARMA (03692) fell 4.9% to HK$17.46,
dipping below the 10-D SMA of HK$17.912.
It hits an intra-day low of HK$17.44, and an intra-day high of HK$18.38. The total
shares traded was 3.05 million, with a value of HK$54.27m. The active buy/sell ratio is
42:58, with net selling turnover of HK$7.62m. GOLDMAN SACHS (ASIA) SEC accounts for
greatest net responsive buying turnover of HK$15m, with volume weighted average price of
HK$17.801. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of
HK$6.38m, with volume weighted average price of HK$17.773. The stock has fallen a combined
8.1% over the past 4 consecutive trading days.
The Hang Seng Index now fell 41 points, or 0.2% to 17,132.

Basic Information
=================

---------------------------------
Nominal 17.460 % Chg -4.90%
High 18.380 Low 17.440
Shares Tr 3.05m Turnover 54.27m
10-D SMA 17.912 %H.V 50.109
20-D SMA 17.443 VWAP 17.798
50-D SMA 17.015 RSI14 50.455
---------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 42:58, with net selling
turnover of HK$7.62m, falling a combined 8.1% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 17.46 -4.90
ALI HEALTH (00241) 3.03 -1.62
TRAD CHI MED (00570) 3.77 -0.26
CSPC PHARMA (01093) 5.87 -0.51
SINOPHARM (01099) 19.98 -1.82
SINO BIOPHARM (01177) 3.00 +1.69
WUXI APPTEC (02359) 33.40 -3.61
CHINARES PHARMA (03320) 5.60 -1.58
JD HEALTH (06618) 20.30 -1.22
GOLDEN THROAT (06896) 3.16 +0.32
-----------------------------------------------
(ed)